Publisher: Adis International
ISSN: 1173-8324
Source: Inpharma, Vol.1, Iss.1374, 2003-01, pp. : 13-14
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Irinotecan plus docetaxel a first-line option for NSCLC
Inpharma, Vol. 1, Iss. 1470, 2005-01 ,pp. :
First-line voriconazole best option for invasive aspergillosis
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 538, 2007-01 ,pp. :
Fludarabine + cyclophosphamide effective for CLL
Inpharma, Vol. 1, Iss. 1598, 2007-01 ,pp. :
Fludarabine superior to chlorambucil in CLL
Inpharma, Vol. 1, Iss. 1269, 2001-01 ,pp. :